We are a provider of SLIT (Sublingual Immunotherapy FDA and Health Canada approved but sublingual liquid solution is an Off-Label type of treatment) and SCIT (FDA and Health Canada approved, Subcutaneous Immunotherapy) products for allergy immunotherapy.
Subcutaneous Immunotherapy
- Allergen solution given by subcutaneous injection
- Customization of allergens in SCIT extracts
- Follows guidelines recommended by AAAAI and ACAAI
- Pre-seasonal management of pollen allergies
- Perennial management of other environmental allergies
- SCIT for venom immunotherapy
Sublingual Immunotherapy
- Allergen solution given under the tongue
- Customization of allergens in SLIT extracts
- Follows guidelines recommended by ACAAI and AAAAI
- Pre-seasonal management of pollen allergies
- Perennial management of other environmental allergens
- Sublingual Liquid Immunotherapy is considered Off-Label use at this time.
Compliance with Safety, Sterility and Accuracy Procedures
- cGMP and USP 797 compliant
- Qualified and annually certified clean room compounding technicians wear sterile gowns, hoods, gloves, shoe covers and face masks
- Environmental monitoring throughout the compounding process
- Aseptic manufacturing facility with HEPA filtered air and laminar flow individual workstations
- Every name patient vial for subcutaneous immunotherapy (SCIT) is sterility tested for 7 days
- Compounding Laboratory is supervised by staff Physician, Quality Assurance/Quality Control supervisor with Health Canada expertise
Other available products
- Diagnostic skin testing extracts for epicutaneous and intradermal methodologies